A Phase I, Open-label, Fixed-order, Single-dose, 2-Part, Crossover Study to Evaluate the Pharmacokinetics of a Formulation of Tricaprilin (AC-SD-01) Including the Effect of Food on Ketone Body Production in Caucasians and Asians
Phase of Trial: Phase I
Latest Information Update: 31 May 2019
Price : $35 *
At a glance
- Drugs Tricaprilin (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Cerecin
- 27 May 2019 Status changed from active, no longer recruiting to completed.
- 04 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 20 Aug 2018 New trial record